Skip to main content

Health condition · Clinically reviewed

Multiple sclerosis, from first symptoms to a long-term treatment plan.

A lifelong condition, but rarely a static one. Early diagnosis and the right disease-modifying therapy change the course of MS for most people.

Jump to treatment
A radiographer guides a patient onto the bed of an advanced 3 Tesla MRI scanner in a London imaging suite

Why trust this guide

  • 01

    Clinically reviewed

    Written by our editorial team and reviewed by a registered UK clinician before publication.

  • 02

    Sourced from guidance

    Checked against NICE NG220, MS Society and MS Trust resources you can see at the end.

  • 03

    Current for 2026

    Reflects modern UK guidance including disease-modifying therapy pathways and MDT rehabilitation.

Key facts

Multiple sclerosis at a glance.

The essentials, in plain English - what it is, the types, and how it’s diagnosed and treated in the UK today.

  • What it is

    A chronic autoimmune disease in which the immune system attacks myelin in the brain and spinal cord, disrupting nerve signalling.

  • Main types

    Relapsing-remitting MS (most common at onset), secondary progressive MS and primary progressive MS.

  • Who it affects

    Usually diagnosed between 20 and 40, roughly three times more common in women than men.

  • Diagnosis

    MRI brain and spine using the McDonald criteria, sometimes with lumbar puncture and visual evoked potentials.

  • Disease-modifying therapy

    A growing range of drugs - interferon beta, glatiramer acetate, natalizumab, ocrelizumab and others - chosen by disease activity.

  • Outlook

    Unpredictable but manageable - most people with relapsing MS retain good function for years with the right treatment.

Why this guide matters

Early treatment changes the trajectory.

MS is unpredictable, but the evidence on early, well-matched treatment is now strong. The three points below shape everything else on this page.

  • Diagnosis needs a specialist

    MRI, the McDonald criteria and exclusion of mimics like MOGAD and NMOSD all sit with neurology, not primary care alone.

  • Disease-modifying therapy works

    Starting the right therapy early reduces relapses and slows long-term disability accumulation for most people with relapsing MS.

  • The MDT matters as much as the drug

    Physiotherapy, occupational therapy and neuropsychology support day-to-day function alongside medication.

How the diagnosis is made

From first symptoms to a confirmed diagnosis.

The steps a UK neurology team will normally follow, in order - so you know what to expect and why.

  1. 01

    Assessing

    Neurological history and exam

    A careful history of episodes - visual loss, sensory change, weakness - plus a full neurological examination.

  2. 02

    Assessing

    Specialist neurology referral

    Suspected MS always warrants referral to a neurologist - this is not a diagnosis made in primary care alone.

  3. 03

    Confirming

    MRI brain and spinal cord

    The key investigation - looking for lesions disseminated in time and space, per the McDonald criteria.

  4. 04

    Confirming

    Lumbar puncture (CSF)

    Checks for oligoclonal bands in the cerebrospinal fluid, supporting the diagnosis when MRI is inconclusive.

  5. 05

    Confirming

    Visual evoked potentials

    Detects slowed optic nerve conduction, useful evidence of a past episode of optic neuritis.

  6. 06

    Preparing

    Excluding mimics

    Blood tests and imaging rule out MOGAD, NMOSD and other conditions that can look like MS.

  7. 07

    Preparing

    Treatment planning

    Once confirmed, an MDT discussion sets out disease-modifying therapy and rehabilitation needs.

Typical timeline: weeks to a few months from first specialist appointment to a confirmed diagnosis.

Symptoms

What MS actually feels like.

The classic mix of visual, sensory and motor symptoms - and the pattern of heat sensitivity that makes MS distinctive.

  • Optic neuritis

    Visual loss or blurring, often with pain on eye movement - frequently the first sign of MS.

  • Sensory disturbance

    Numbness, tingling or pins and needles, often starting in one limb or one side of the body.

  • Limb weakness

    Weakness in an arm or leg, sometimes with stiffness or spasticity, reflecting a spinal cord lesion.

  • Lhermitte's sign

    An electric-shock sensation running down the spine and limbs on neck flexion.

  • Ataxia and coordination problems

    Unsteady walking, poor balance or clumsy hand movements from cerebellar involvement.

  • Bladder and bowel dysfunction

    Urgency, frequency, incomplete emptying or constipation - common and often under-reported.

  • Fatigue and cognitive changes

    Overwhelming fatigue and difficulties with memory, attention or processing speed.

  • Uhthoff's phenomenon

    Temporary worsening of symptoms with heat - a hot bath, exercise or fever - that settles on cooling.

Treatment

How MS is treated in the UK.

Disease-modifying therapy chosen by disease activity, relapse management, symptom control and MDT rehabilitation working together.

  • Interferon beta

    An injectable disease-modifying therapy that reduces relapse frequency in relapsing-remitting MS.

  • Glatiramer acetate

    A well-tolerated injectable option, often chosen for its favourable long-term safety profile.

  • Natalizumab

    A highly effective infusion therapy for active disease, with careful monitoring for rare side effects.

  • Ocrelizumab

    A B-cell depleting infusion licensed for relapsing and, in selected cases, primary progressive MS.

  • High-dose corticosteroids

    Used to shorten and reduce the severity of an acute relapse, not to alter long-term disease course.

  • Spasticity and pain management

    Physiotherapy alongside medication such as baclofen or gabapentin for stiffness and neuropathic pain.

  • Bladder and fatigue management

    Targeted strategies and medication for bladder dysfunction, plus energy-conservation approaches for fatigue.

  • MDT rehabilitation

    Physiotherapy, occupational therapy and neuropsychology working together to maintain function and independence.

What this guide is based on

The sources behind every claim on this page.

UK national guidance and specialist society standards, current at the time of last review.

Key references

Guidelines and standards we relied on.

A quiet reminder

This guide is for information, not medical advice.

Your neurologist knows your history and imaging and can tell you which parts apply to you. If in doubt, get seen.

  • NICE. Multiple sclerosis in adults: management (NG220).

  • MS Society. Information and support for people with MS.

  • MS Trust. Treatment and symptom management resources.

  • Association of British Neurologists. Guidance on disease-modifying therapies.

Red flags

When MS needs urgent attention.

Most MS is managed with routine specialist follow-up. These are the situations that aren’t - and where urgent review is needed.

  • Sudden severe visual loss

    Rapid loss of vision in one eye with pain on movement needs same-day ophthalmology or neurology assessment.

  • Rapidly worsening weakness

    Fast-progressing limb weakness or new difficulty walking warrants urgent neurological review.

  • Bladder or bowel incontinence with back pain

    This combination raises concern for cauda equina syndrome and needs emergency assessment.

  • Suspected pregnancy on disease-modifying therapy

    Some therapies are not safe in pregnancy - contact the MS team promptly to review medication.

  • Signs of infection on immunosuppressive therapy

    Fever or new illness while on natalizumab, ocrelizumab or similar drugs needs prompt specialist advice.

  • Severe depression or suicidal thoughts

    Mental health difficulties are common in MS and deserve urgent support - contact the GP or crisis services.

  • New neurological symptoms in known MS

    A genuinely new symptom pattern should always be reported rather than assumed to be a routine relapse.

  • Progressive Multifocal Leukoencephalopathy risk

    Rare but serious complication of some therapies - new cognitive or visual change on natalizumab needs urgent review.

Living with it

A lifelong condition, managed one day at a time.

Four things that make the biggest difference day to day - pacing energy, managing heat, building a support team and planning ahead.

A quiet reminder

MS looks different in every person.

What works for one person with MS may not suit another - your MS nurse and neurologist can tailor the plan to you.

  1. 01 Energy

    Pace your activity

    Spreading tasks across the day and resting proactively helps manage MS fatigue before it overwhelms you.

  2. 02 Heat

    Manage Uhthoff's phenomenon

    Cooling vests, air conditioning and timing exercise for cooler parts of the day reduce heat-triggered symptoms.

  3. 03 Team

    Build your MDT

    Physiotherapy, occupational therapy and MS nurse support make a real difference to daily function.

  4. 04 Plan

    Plan pregnancy with your team

    Discuss disease-modifying therapy and family planning early - many options can be managed safely with the right timing.

Frequently asked

Everything we get asked about MS.

Quick answers on diagnosis, disease-modifying therapy and planning for the future.

  • What is multiple sclerosis?

    A chronic autoimmune disease in which the immune system attacks the myelin sheath around nerves in the brain and spinal cord, disrupting the signals that control movement, sensation and other functions.

  • What are the main types of MS?

    Relapsing-remitting MS is the most common pattern at diagnosis, with distinct attacks and recovery periods. Some people later develop secondary progressive MS, with gradual worsening. Primary progressive MS involves steady decline from the start without distinct relapses.

  • How is MS diagnosed?

    Diagnosis relies on MRI of the brain and spinal cord, using the McDonald criteria to show lesions disseminated in time and space. A lumbar puncture for oligoclonal bands and visual evoked potentials can support the diagnosis, and other conditions such as MOGAD and NMOSD are excluded.

  • What is a disease-modifying therapy?

    These are medications - such as interferon beta, glatiramer acetate, natalizumab and ocrelizumab - that reduce the frequency and severity of relapses and slow the accumulation of damage. The choice depends on how active the disease is and personal circumstances.

  • Can I have children if I have MS?

    Yes - with planning. Many disease-modifying therapies need to be stopped or switched before conception, and your MS team can help time this safely alongside contraception and pregnancy planning.

  • What is Uhthoff's phenomenon?

    A temporary worsening of existing MS symptoms triggered by heat - such as a hot bath, exercise or fever. It is not a new relapse and resolves once the body cools down.

Related content

Keep reading.

Pulse Healthcare concierge

Send us your enquiry

A concierge service for UK private healthcare. We match you with the best vetted clinics and consultants in our network - they then contact you directly.

So we can match you to the right clinician close to you.

We reply to every enquiry within 24 hours (Mon–Fri). Confidential - your details are never shared outside our vetted consultant network.